P.A.W. Capital Corp Abbott Laboratories Transaction History

P.A.W. Capital Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$102.07 - $123.37 $612,420 - $740,220	-6,000 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $52,500 - $57,210	-500 Reduced 7.69%	6,000 $657,000
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $45,820 - $55,645	-500 Reduced 7.14%	6,500 $707,000
Q2 2020 Jul 27, 2020	SELL	$76.57 - $98.0 $76,570 - $98,000	-1,000 Reduced 12.5%	7,000 $640,000
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $40,920 - $44,370	-500 Reduced 5.88%	8,000 $669,000
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $36,440 - $42,500	-500 Reduced 5.56%	8,500 $715,000
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $65,560 - $74,270	-1,000 Reduced 10.0%	9,000 $651,000
Q2 2018 Jul 25, 2018	SELL	$57.57 - $63.54 $115,140 - $127,080	-2,000 Reduced 16.67%	10,000 $610,000
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $107,360 - $114,940	-2,000 Reduced 14.29%	12,000 $685,000
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $672,840 - $750,960	14,000	14,000 $747,000

3,265

1.31B

9.64M

8.27M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.